Table 3.
Prevalence of co-infections amongst AMSM and ATGW enrolled in the PrEP1519 study in Salvador, Brazil, from April 2019 to February 2021
| Microorganisms | Total (N = 246) n (%) | AMSM | ATGW |
|---|---|---|---|
| (n = 231) | (n = 15) | ||
| n (%) | n (%) | ||
| MH + UU | 16 (6.5) | 14 (6.9) | 2 (13.3) |
| MG + UU | 3 (1.2) | 3 (1.3) | - |
| MG + MH | 1 (0.4) | 1 (0.4) | - |
| MH + UP | 1 (0.4) | 1 (0.4) | - |
| UP + UU | 1 (0.4) | 1 (0.4) | - |
| MG + MH + UU | 3 (1.2) | 3 (1.3) | - |
| Total no. of participants with co-infections | 25 (10.2) | 23 (9.9) | 2 (13.3) |
Legend: MG Mycoplasma genitalium, MH Mycoplasma hominis, UP Ureaplasma parvum, UU Ureaplasma urealyticum. AMSM adolescent men who have sex with men, ATGW adolescent transgender women. N = total number of participants screened. Totals in bold indicate the highest prevalence (over 5%)